Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1385941.
- Also identified by PMC identifier 1004773.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sixteen cases of either a pityriasiform or discoid eczematous rash occurring in patients with rheumatoid arthritis receiving treatment with gold (sodium aurothiomalate and auranofin) were studied. The results suggest that this is a dose related, not allergic, reaction to gold. The development of this rash is not an absolute indication to stop treatment with gold. Control can often be effected with potent topical steroids or a reduction in the dose or frequency of treatment with gold.
Medical subject headings
- Arthritis, Rheumatoid
- Auranofin
- Drug Eruptions
- Eczema
- Gold Sodium Thiomalate
- Pityriasis